News
The new research center at the University of Michigan and Oregon Health & Science University intends to develop a clinical ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
In 2026, CVS Health has decided to exit the individual exchange business where Aetna independently operates. In a first ...
At this year’s Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive spoke with John Beardsley, senior ...
Becky Davis of Charles River Associates predicts that an influx of new and oral GLP-1 drugs, along with pricing pressures ...
An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...
The victims of intimate partner violence were found to have more menopause symptoms, according to the results of a Turkish ...
Asembia Specialty Pharmacy Summit, Becky Davis, principal at Charles River Associates, discussed how employer-based insurance ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Kathi Henson, senior vice president of patient services, nursing and quality at Orsini, spoke with MHE editors at this year’s Asembia Specialty Pharmacy Summit in Las Vegas about how analytics and AI ...
Asembia Specialty Pharmacy Summit in Las Vegas, John Beardsley, senior vice president of corporate business development at CoverMyMeds, and Fauzea Husain, vice president of public policy at McKesson, ...
Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results